Major technology and science trends converge and make 2020 onward unique in our ability to deliver genomics-driven care to mass populations. In this session, we will cover how AI-based genomic interpretation is a game-changing technology that helps form new delivery models that are more aligned with patient outcomes. Learn how Boston Children's Hospital is using these transformative technologies to disrupt the market.
Presented by Einat Metzer, CEO / Emedgene
28:48Presented by Amanda Parsons, MD, MBA, Deputy, Chief Medical Officer MetroPlus Health Plan / MetroPlusHealth
37:18Presented by Lisa Gulker, DNP RN ACNP-BC, Chief Medical Officer MetroPlus Health Plan / Cerner
14:22Presented by Erin Monteverdi, Executive Director / Quest Information Ventures and Zach Berg, Partner Engagement Director / hc1
19:59Presented by Carol Ross, Global Product Manager, Clinical Informatics, Beckman Coulter Inc. and Douglas D. Mueller, Lab Director / Mason District Hospital
